Plasminogen Activator Inhibitor-1 (PAI-1)

The Plasminogen Activator Inhibitor-1 (PAI-1) test contains 1 test with 1 biomarker.

Increased activity is associated with increased risk of arterial thrombosis, such as with unexplained premature myocardial infarction. As an acute phase reactant, the activity is increased after an acute event. Studies suggest PAI-1 may be a prognostic marker in early stage breast cancer.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: PAI-1, PAI-1 (Plasminogen Activator Inhibitor-1), Plasminogen Activator Inhibitor-1, Plasminogen Activator Inhibitor1 PAI1

Plasminogen Activator

*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.